Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in a Randomized Phase 2 Trial of Regorafenib in Advanced Gastric Cancer
Version 2 2024-06-19, 00:50Version 2 2024-06-19, 00:50
Version 1 2021-01-12, 16:03Version 1 2021-01-12, 16:03
conference contribution
posted on 2024-06-19, 00:50authored byA Vasista, A Martin, N Pavlakis, K Sjoquist, S Snow, D Jonker, YJ Chua, R Epstein, A Bonaventura, M Khasraw, S Varma, N Singhal, D Ransom, F Aubin, R Burkes, H Lim, F Lemay, S Begbie, M Stockler, B Kiely
Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in a Randomized Phase 2 Trial of Regorafenib in Advanced Gastric Cancer